NiKem Research receives certification for GLP Bioanalysis
NiKem Research has provided for many years bioanalytical support both for its in vitro ADME(T) and in vivo PK services associated to various drug discovery programs and as a standalone capability. The company is now able to offer bioanalysis as a GLP service to support clients preclinical PK and toxicology studies.
Giuseppe Giardina, CEO & Managing Director of NiKem, said “This new product is an important step in NiKem’s continuing expansion of its high quality, cost effective services to support progression of our clients’ drug discovery programmes”.
Most read news
Organizations
Other news from the department politics & laws
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.